Zhitong Financial App News, Shijiyao Group (02005.HK) issued an announcement that the Group has obtained approval from the China National Drug Administration for the production of peritoneal dialysis solution (bicarbonate-G 1.5%) (2000ml), which is considered to have passed the consistency evaluation. It is mainly used for peritoneal dialysis in patients with chronic renal failure, and is used when hypermagnesemia has not been fully improved.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.